On May 13, 2021, Curi Bio’s CSO, Dr. Nicholas Geisse, was a panelist for Device Connect by Life Science Washington hosted by Product Creation Studio.

Moderated by Sean MacLeod, CEO of FenoLogica Biosciences, the full panelist line-up included:

We wanted to share the great discussion here for anyone who missed. Enjoy!

About Device Connect

Over the past year, the entire world has been focused on medical technologies associated with COVID: diagnostics, vaccines, and drugs. The top medical minds from our state have been front-runners in these discoveries. With these rapid breakthroughs in the spotlight, it’s easy to overlook the tools used to create these types of technologies in the first place. Washington State has long been a leader in the development of life science tools that enable breakthrough discovery. We have a rich and deep history leading the way in oncology, genomics, proteomics, and synthetic biology. In this DeviceConnect, we’ll talk to active members and leaders in our region’s life science tools industry. Gain insight into the ground that’s been covered, and what breakthroughs are on the horizon.

Image: Curi Bio 96-well NanoSurface plate